Project Grant R35GM166720
- The National Institute of General Medical Sciences, operating as part of the Department of Health and Human Services National Institutes of Health, awarded the University of Utah $423,500 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The award funds research investigating the biological functions, biosynthesis, and dynamic regulations of RNA chemical modifications. The research program addresses three key challenges: identifying proteins that...
- The National Institute of General Medical Sciences awarded the University of Utah $885,637 in project grant funding on March 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The University of Utah, through its Office of Sponsored Projects Division, will conduct a five-year investigation into the molecular and metabolic adaptations that enable apicomplexan parasites—particularly Plasmodium species that cause malaria—to survive and replicate within host cells....
- The National Institute of General Medical Sciences awarded the University of Utah $392,942 on May 22, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on the regulation of single-cell migration in vivo. The award funds investigation into how focal adhesion structures form and function during cell migration in living organisms, specifically using zebrafish larval skin as a model system to directly visualize focal adhesion dynamics in highly...
- The National Institute of General Medical Sciences awarded the University of Utah $423,500 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational and statistical tools for measuring and analyzing CRISPR genome editing outcomes. The recipient will create algorithms to quantify complex editing outcomes across diverse editor types and improve detection of unexpected editing byproducts that current methods miss. The University of Utah...
- The National Institute of General Medical Sciences awarded the University of Utah $500,500 on March 2, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and apply nicotinic acetylcholine receptor targeted peptides for biomedical research. Over the five-year performance period through December 31, 2030, the University of Utah will develop a library of selective probes targeting nicotinic acetylcholine receptor (nAChR) subtypes currently lacking selective...
- The National Institute of General Medical Sciences awarded the University of Miami $501,165 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support structural and biophysical research on three human membrane proteins with significance to cardiovascular health, hemostasis, and inflammation. The funded research determines the structures and functional mechanisms of connexin channels, which coordinate electrical and metabolic activity in cardiac...
- The National Institute of General Medical Sciences awarded the University of Utah $125,000 on August 14, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research elucidating the role of Wnt/beta-catenin signaling in mitochondrial metabolism and cell behavior. The project investigates the molecular mechanisms by which beta-catenin and its downstream target gene c-myc regulate expression of the mitochondrial pyruvate carrier (MPC1 and MPC2), transmembrane...
- The National Institute of General Medical Sciences awarded $370,550 to the University of California, San Diego on May 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) for development of the Intracellular Protein Organization Landscape (IPOL), a quantitative computational framework that characterizes cell types and states based on spatial protein organization rather than molecular composition. The award funds research integrating high-resolution imaging,...
- The National Institute of General Medical Sciences awarded the University of Utah $556,000 on August 25, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to advance precise genome editing methods in zebrafish. The award funds development and optimization of a base-substitution editing technique using single-strand DNA donors and a nickase version of Cas9 (Cas9D10A) to direct homology-directed repair. The funded work will improve editing efficiency, establish and...
- The National Institute of General Medical Sciences awarded the University of Illinois $380,350 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to systematically characterize human disease-associated protein complexes. The recipient will develop machine learning approaches to identify biologically relevant protein complex variants from over 32,000 mass spectrometry experiments, construct cell-type-specific protein complex maps focusing on early embryonic...
The National Institute of General Medical Sciences awarded $423,500 to the University of Utah on August 15, 2026, to map inter-organ communication networks by identifying and characterizing circulating proteins that coordinate multi-organ functions under normal and disease conditions. The project integrates experimental and computational techniques to identify inter-organ signaling factors in blood, develop tools to determine tissue targets of circulating proteins, and apply AI-based prediction methods to characterize hormone-receptor interactions. The work proceeds through four independent but cross-validating aims: identifying inter-organ factors from prior organ-secreted protein datasets, discovering disease-induced secreted proteins that influence pathology, developing "receive-ome" tools to map tissue targets, and adapting AI tools to predict hormones and receptors. Initial in vivo experiments use Drosophila as a model organism, followed by validation in zebrafish and mice. This research addresses a gap in systematic mapping of inter-organ communication analogous to brain connectome projects, overcoming technical barriers posed by the low abundance, regulated secretion, and complex non-cell-autonomous functions of circulating signaling proteins. Work is performed in Salt Lake City, Utah, with a period of performance through April 30, 2031. This is a Project Grant under the National Institute of General Medical Sciences' Biomedical Research and Research Training program (CFDA 93.859), which supports basic research to advance understanding of biological processes and lay foundations for disease diagnosis, treatment, and prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $423.5k | 8/11/26 |